Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges.

Jiang, Long; Wang, Lu-Ya; Cheng, Xiao-Shu

Jiang, Long; Wang, Lu-Ya; Cheng, Xiao-Shu.

Afiliación

Jiang L; Department of Cardiology, the Second Affiliated Hospital of Nanchang University.
Wang LY; Beijing An Zhen Hospital, Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Institute of Heart, Lung and Blood Vessel Diseases.
Cheng XS; Department of Cardiology, the Second Affiliated Hospital of Nanchang University.

J Atheroscler Thromb ; 25(8): 665-673, 2018 Aug 01.

Article en En | MEDLINE | ID: mdl-29899171

Asunto(s)

Anticolesterolemiantes/uso terapéutico; Hiperlipoproteinemia Tipo II/terapia; Receptores de LDL/genética; Animales; Terapia Combinada; Terapia Genética; Humanos; Hiperlipoproteinemia Tipo II/genética; Hiperlipoproteinemia Tipo II/metabolismo

Palabras clave

CRISPR/Cas9; Familial hypercholesterolemia; LncRNA; MicroRNA; Treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de LDL / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Límite: Animals / Humans Idioma: En Revista: J Atheroscler Thromb Asunto de la revista: ANGIOLOGIA Año: 2018 Tipo del documento: Article Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google